Forian Stock (NASDAQ:FORA)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.15

52W Range

$1.64 - $2.71

50D Avg

$2.10

200D Avg

$2.11

Market Cap

$67.25M

Avg Vol (3M)

$26.54K

Beta

0.99

Div Yield

-

FORA Company Profile


Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

47

IPO Date

Mar 03, 2021

Website

FORA Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 22Dec 21
Information and Software$26.19M$14.95M
Service$1.55M$1.12M
Product and Service, Other$274.26K$804.94K

Fiscal year ends in Dec 25 | Currency in USD

FORA Financial Summary


Dec 25Dec 24Dec 23
Revenue$30.26M$20.15M$20.48M
Operating Income$-2.47M$-6.99M$-5.60M
Net Income$-2.87M$-3.77M$11.11M
EBITDA$-2.24M$-2.91M$2.75M
Basic EPS$-0.09$-0.12$0.36
Diluted EPS$-0.09$-0.12$0.36

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q2 25Aug 13, 25 | 4:30 PM
Q1 25May 14, 25 | 4:30 PM
Q3 24Nov 13, 24 | 4:30 PM

Peer Comparison


TickerCompany
TCRXTScan Therapeutics, Inc.
LUNGPulmonx Corporation
AMWLAmerican Well Corporation
ASRTAssertio Holdings, Inc.
NTRBNutriband Inc.
XBITXBiotech Inc.
BEATHeartBeam, Inc.
GEGGreat Elm Group, Inc.
ONMDOneMedNet Corporation